These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1043 related articles for article (PubMed ID: 29098902)

  • 1. Design, synthesis, and pharmacological evaluation of 2-amino-5-nitrothiazole derived semicarbazones as dual inhibitors of monoamine oxidase and cholinesterase: effect of the size of aryl binding site.
    Tripathi RKP; M Sasi V; Gupta SK; Krishnamurthy S; Ayyannan SR
    J Enzyme Inhib Med Chem; 2018 Dec; 33(1):37-57. PubMed ID: 29098902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of a Library of 3,4-(Methylenedioxy)aniline-Derived Semicarbazones as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase: Design, Synthesis, and Evaluation.
    Tripathi RK; Rai GK; Ayyannan SR
    ChemMedChem; 2016 Jun; 11(11):1145-60. PubMed ID: 27135466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, in vitro MAO-B inhibitory evaluation, and computational studies of some 6-nitrobenzothiazole-derived semicarbazones.
    Tripathi RK; Goshain O; Ayyannan SR
    ChemMedChem; 2013 Mar; 8(3):462-74. PubMed ID: 23325700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semicarbazones, thiosemicarbazone, thiazole and oxazole analogues as monoamine oxidase inhibitors: Synthesis, characterization, biological evaluation, molecular docking, and kinetic studies.
    Qazi SU; Naz A; Hameed A; Osra FA; Jalil S; Iqbal J; Shah SAA; Mirza AZ
    Bioorg Chem; 2021 Oct; 115():105209. PubMed ID: 34364054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzimidazole-derived carbohydrazones as dual monoamine oxidases and acetylcholinesterase inhibitors: design, synthesis, and evaluation.
    Kumar S; Jaiswal S; Gupta SK; Ayyannan SR
    J Biomol Struct Dyn; 2024 Jun; 42(9):4710-4729. PubMed ID: 37345530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, Synthesis, and Evaluation of 2-Amino-6-nitrobenzothiazole-Derived Hydrazones as MAO Inhibitors: Role of the Methylene Spacer Group.
    Tripathi RK; Ayyannan SR
    ChemMedChem; 2016 Jul; 11(14):1551-67. PubMed ID: 27332045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and biochemical evaluation of novel multi-target inhibitors as potential anti-Parkinson agents.
    Carradori S; Ortuso F; Petzer A; Bagetta D; De Monte C; Secci D; De Vita D; Guglielmi P; Zengin G; Aktumsek A; Alcaro S; Petzer JP
    Eur J Med Chem; 2018 Jan; 143():1543-1552. PubMed ID: 29126727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and evaluation of 7-substituted coumarin derivatives as multimodal monoamine oxidase-B and cholinesterase inhibitors for the treatment of Alzheimer's disease.
    Joubert J; Foka GB; Repsold BP; Oliver DW; Kapp E; Malan SF
    Eur J Med Chem; 2017 Jan; 125():853-864. PubMed ID: 27744252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morpholine-based chalcones as dual-acting monoamine oxidase-B and acetylcholinesterase inhibitors: synthesis and biochemical investigations.
    Sasidharan R; Eom BH; Heo JH; Park JE; Abdelgawad MA; Musa A; Gambacorta N; Nicolotti O; Manju SL; Mathew B; Kim H
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):188-197. PubMed ID: 33430657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (Thiazol-2-yl)hydrazone derivatives from acetylpyridines as dual inhibitors of MAO and AChE: synthesis, biological evaluation and molecular modeling studies.
    D'Ascenzio M; Chimenti P; Gidaro MC; De Monte C; De Vita D; Granese A; Scipione L; Di Santo R; Costa G; Alcaro S; Yáñez M; Carradori S
    J Enzyme Inhib Med Chem; 2015 Dec; 30(6):908-19. PubMed ID: 25807300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis and biological evaluation of 3,4-dihydro-2(1H)-quinoline-O-alkylamine derivatives as new multipotent cholinesterase/monoamine oxidase inhibitors for the treatment of Alzheimer's disease.
    Sang Z; Pan W; Wang K; Ma Q; Yu L; Liu W
    Bioorg Med Chem; 2017 Jun; 25(12):3006-3017. PubMed ID: 28487125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental and Computational Evaluation of Piperonylic Acid Derived Hydrazones Bearing Isatin Moieties as Dual Inhibitors of Cholinesterases and Monoamine Oxidases.
    Vishnu MS; Pavankumar V; Kumar S; Raja AS
    ChemMedChem; 2019 Jul; 14(14):1359-1376. PubMed ID: 31177620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: Synthesis, biological evaluation and docking study.
    Krátký M; Vu QA; Štěpánková Š; Maruca A; Silva TB; Ambrož M; Pflégr V; Rocca R; Svrčková K; Alcaro S; Borges F; Vinšová J
    Bioorg Chem; 2021 Nov; 116():105301. PubMed ID: 34492558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyridoxine-resveratrol hybrids Mannich base derivatives as novel dual inhibitors of AChE and MAO-B with antioxidant and metal-chelating properties for the treatment of Alzheimer's disease.
    Yang X; Qiang X; Li Y; Luo L; Xu R; Zheng Y; Cao Z; Tan Z; Deng Y
    Bioorg Chem; 2017 Apr; 71():305-314. PubMed ID: 28267984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploration of a library of piperonylic acid-derived hydrazones possessing variable aryl functionalities as potent dual cholinesterase and monoamine oxidase inhibitors.
    Kumar VP; Vishnu MS; Kumar S; Jaiswal S; Ayyannan SR
    Mol Divers; 2023 Dec; 27(6):2465-2489. PubMed ID: 36355337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against Alzheimer's disease.
    Li F; Wang ZM; Wu JJ; Wang J; Xie SS; Lan JS; Xu W; Kong LY; Wang XB
    J Enzyme Inhib Med Chem; 2016; 31(sup3):41-53. PubMed ID: 27384289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolinic Carboxylic Acid Derivatives as Potential Multi-target Compounds for Neurodegeneration: Monoamine Oxidase and Cholinesterase Inhibition.
    Khan NA; Khan I; Abid SMA; Zaib S; Ibrar A; Andleeb H; Hameed S; Iqbal J
    Med Chem; 2018; 14(1):74-85. PubMed ID: 28545383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4,6-Diphenylpyrimidine Derivatives as Dual Inhibitors of Monoamine Oxidase and Acetylcholinesterase for the Treatment of Alzheimer's Disease.
    Kumar B; Dwivedi AR; Sarkar B; Gupta SK; Krishnamurthy S; Mantha AK; Parkash J; Kumar V
    ACS Chem Neurosci; 2019 Jan; 10(1):252-265. PubMed ID: 30296051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease.
    Lan JS; Ding Y; Liu Y; Kang P; Hou JW; Zhang XY; Xie SS; Zhang T
    Eur J Med Chem; 2017 Oct; 139():48-59. PubMed ID: 28797883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 4-(3-Nitrophenyl)thiazol-2-ylhydrazone derivatives as antioxidants and selective hMAO-B inhibitors: synthesis, biological activity and computational analysis.
    Secci D; Carradori S; Petzer A; Guglielmi P; D'Ascenzio M; Chimenti P; Bagetta D; Alcaro S; Zengin G; Petzer JP; Ortuso F
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):597-612. PubMed ID: 30727777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.